Skip to main content
. 2019 Nov 7;7:450. doi: 10.3389/fped.2019.00450

Table 2.

Outcomes of interest.

Parameters SP1 (N = 16) SP2 (N = 10) SP3 (N = 28) Total procedures (N = 54) SP1 + SP2 + SP3 Comparison SP1 + SP2/SP3 (p)
Duration of remifentanil administration (minutes), median (IQ 25–75) 6
(2–12)
8
(7–11)
4
(2–4)
4
(3–8)
<0.001
Cumulative dose of remifentanil (μg/kg), median (IQ 25–75) 3
(1–6)
3
(2–3.3)
0.6
(0.3–1)
1 (0.6–3) <0.001
Total laryngoscopic time (minutes), median (IQ 25–75) 5
(2–8)
3
(1–4)
5
(2–8)
4
(2–8)
0.62
Attempts for successful intubation, n (%) 0.44
 First attempt 4 (25) 5 (50) 9 (32) 18 (33)
 Second attempt 9 (56) 4 (40) 10 (36) 23 (43)
 Third attempt 3 (19) 1 (10) 8 (29) 12 (22)
 Fourth attempt 0 (0) 0 (0) 1 (4) 1 (2)
Change in heart rate > 50 % of baseline during procedure, n (%) 5 (31) 2 (20) 5 (18) 12 (23) 0.51
Change in oxygen saturation > 50% of baseline during procedure, n (%) 6 (38) 5 (50) 9 (32) 20 (37) 0.41
Change in mean blood pressure > 50% of baseline procedure, n (%) 0 (0) 0 (0) 2 (7) 2 (4) 0.49
Change in respiratory rate > 50% of baseline procedure, n (%) 2 (13) 2 (20) 2 (7) 6 (11) 0.42
Additional Epinephrine given, n (%) 1 (6) 1 (10) 0 (0) 2 (4) 0.23
Additional Naloxone given, n (%) 0 (0) 0 (0) 0 (0) 0 (0)
Additional Mivacurium given, n (%) 0 (0) 0 (0) 1 (4) 1 (2)
APN score (0–10)a, median (IQ 25–75)
 Before intubation 2 (0–7) 1 (0–1) 5 (2–7) 2 (0–5) 0.09
 During intubation 0 (0–2) 0 (0–1) 1 (0–3) 1 (0–2) 0.13
 After intubation 0 (0–1) 0 (0–0) 0 (0–1) 0 (0–0) 0.52
Adverse events, n (%)
 Chest wall rigidity 3 (19) 0 (0) 3 (11) 6 (11) 1.0
 Other respiratory problemsb 3 (19) 2 (20) 0 (0) 5 (9) 0.02
 Laryngospasm 0 (0) 1 (10) 0 (0) 1 (2) 0.48
 Total number of adverse eventsc 6 (38) 3 (30) 3 (11) 12 (22) 0.05

IQ: interquartile. SD: standard deviation.

a

APN: Acute Pain in Newborn infants score of 0 (no pain) to 10 (highest pain) comprising 3 assessments (facial responses, limb movements, and vocal expression of pain). The APN scores were available for 23 intubations.

b

Other respiratory problems were defined as a prolonged desaturation requiring a transient increase of ventilatory settings at an unexpected level, excluding chest wall rigidity.

c

Number of adverse events per total number of procedures.